Caearean section · women diagnosed with gestational diabetes; 24‐30 weeks' gestation; singleton pregnancy.
It is very uncertain whether oral anti‐diabetic pharmacological therapies changes caearean section compared with placebo ‐ maternal outcomes (very low certainty).
1 finding from 1 review
Hypertensive disorders of pregnancy ‐ not reported · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Development of type 2 diabetes ‐ not measured · women diagnosed with gestational diabetes; 24‐30 weeks' gestation; singleton pregnancy.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
Glibenclamide showed no clear difference in caesarean section compared with acarbose ‐ maternal outcomes (low certainty).
1 finding from 1 review
Development of type 2 diabetes ‐ not measured · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perineal trauma ‐ not reported · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Return to pre‐pregnancy weight ‐ not measured · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Postnatal depression ‐ not measured · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Induction of labour ‐ not reported · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perineal trauma · women diagnosed with gestational diabetes; 24‐30 weeks' gestation; singleton pregnancy.
It is very uncertain whether oral anti‐diabetic pharmacological therapies changes perineal trauma compared with placebo ‐ maternal outcomes (very low certainty).
1 finding from 1 review
Return to pre‐pregnancy weight ‐ not measured · women diagnosed with gestational diabetes; 24‐30 weeks' gestation; singleton pregnancy.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Postnatal depression ‐ not measured · women diagnosed with gestational diabetes; 24‐30 weeks' gestation; singleton pregnancy.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Induction of labour · women diagnosed with gestational diabetes; 24‐30 weeks' gestation; singleton pregnancy.
It is very uncertain whether oral anti‐diabetic pharmacological therapies changes induction of labour compared with placebo ‐ maternal outcomes (very low certainty).
1 finding from 1 review
Overall survival (Death) · patients with advanced and/or metastatic colorectal cancer
IRI with fluoropyrimidines showed no clear difference in overall survival (Death) compared with single agent IRI (low certainty).
1 finding from 1 review
Progression‐free survival (PSF) · patients with advanced and/or metastatic colorectal cancer
IRI with fluoropyrimidines probably leads to lower progression‐free survival (Disease progression) compared with single agent IRI (moderate certainty).
1 finding from 1 review
Grade 3/4 diarrhea · patients with advanced and/or metastatic colorectal cancer
IRI with fluoropyrimidines probably leads to lower grade 3/4 diarrhea compared with single agent IRI (moderate certainty).
1 finding from 1 review
Grade 3/4 nausea · patients with advanced and/or metastatic colorectal cancer
IRI with fluoropyrimidines showed no clear difference in grade 3/4 nausea compared with single agent IRI (low certainty).
1 finding from 1 review
Ambulation · adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery)
It is very uncertain whether laminectomy plus radiotherapy changes ambulation At four months compared with radiotherapy (very low certainty).
1 finding from 1 review
Survival At four months · adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery)
It is very uncertain whether laminectomy plus radiotherapy changes survival At four months compared with radiotherapy (very low certainty).
1 finding from 1 review
Reduced use of analgesics · adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery)
It is very uncertain whether laminectomy plus radiotherapy changes reduction in analgesic use compared with radiotherapy (very low certainty).
1 finding from 1 review